Geode Capital Management’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
416,122
+55,730
| +15% | +$1.63M | ﹤0.01% | 2231 |
|
|
2025
Q1 | $9.27M | Buy |
360,392
+26,366
| +8% | +$678K | ﹤0.01% | 2336 |
|
|
2024
Q4 | $9.65M | Sell |
334,026
-3,998
| -1% | -$115K | ﹤0.01% | 2403 |
|
|
2024
Q3 | $8.03M | Sell |
338,024
-22,096
| -6% | -$525K | ﹤0.01% | 2498 |
|
|
2024
Q2 | $6.23M | Buy |
360,120
+271,902
| +308% | +$4.7M | ﹤0.01% | 2603 |
|
|
2024
Q1 | $1.97M | Buy |
88,218
+8,910
| +11% | +$199K | ﹤0.01% | 3114 |
|
|
2023
Q4 | $1.45M | Buy |
79,308
+2,509
| +3% | +$46K | ﹤0.01% | 3206 |
|
|
2023
Q3 | $1.33M | Buy |
76,799
+2,775
| +4% | +$48.2K | ﹤0.01% | 3210 |
|
|
2023
Q2 | $1.35M | Buy |
74,024
+38,684
| +109% | +$704K | ﹤0.01% | 3240 |
|
|
2023
Q1 | $606K | Buy |
35,340
+692
| +2% | +$11.9K | ﹤0.01% | 3579 |
|
|
2022
Q4 | $805K | Buy |
34,648
+3,238
| +10% | +$75.2K | ﹤0.01% | 3457 |
|
|
2022
Q3 | $696K | Buy |
31,410
+8,841
| +39% | +$196K | ﹤0.01% | 3567 |
|
|
2022
Q2 | $434K | Sell |
22,569
-37,005
| -62% | -$712K | ﹤0.01% | 3842 |
|
|
2022
Q1 | $2.13M | Buy |
59,574
+21,120
| +55% | +$754K | ﹤0.01% | 3229 |
|
|
2021
Q4 | $3.35M | Buy |
38,454
+1,686
| +5% | +$147K | ﹤0.01% | 3113 |
|
|
2021
Q3 | $4.22M | Buy |
+36,768
| New | +$4.22M | ﹤0.01% | 3010 |
|